A few days ago, BASF set up an industry-leading biologically-based acrylamide production plant in the Nanjing Chemical Industry Park in China, which can produce over 50,000 tons of acrylamide per year.
Acrylamide is used to produce water-soluble flocculants, making wastewater treatment, paper making, mineral processing and crude oil recovery more efficient and resource efficient.
BASF has started producing biologically-based acrylamide in Suffolk, Va., USA since 2014. A new biologically-based acrylamide plant was put into operation in Bradford, England in 2016. After the project was successfully put into operation in Nanjing, BASF has In the world's major markets have three sets of the industry's most advanced production plant.
BASF said: "The completion of the BioACM plant is an important milestone in the history of BASF Nanjing and has laid the groundwork for future expansion. The new polyacrylamide production line is under construction and is expected to be operational by 2018. By We further strengthen BASF's position as a preferred partner in the paper and water treatment industry for the investment in upstream and downstream production facilities. '
Compared with the traditional high-pressure, high-energy copper catalytic process, the waste produced by the enzymatic biocatalytic process is greatly reduced, which can be carried out at room temperature and under normal atmospheric conditions, which helps to save energy and enhance environmental compatibility. Meanwhile, By-products are also less.